Drugs removed from the market If the Food and Drug Administration (FDA) deems a drug on our formulary to be unsafe or the drugs manufacturer removes the drug from the market, we will immediately remove the drug from our formulary and provide notice to members who take the drug
Advanced regenerative therapies to restore tissue, cellular, metabolic & mitochondrial health & improve energy PRP, stem cells, peptides, ozone, and exosomes activate skin repair & rejuvenation & heal joints, tissues & tendons Personalized IV therapies, including NAD+, Methylene Blue, Intravenous Red light & more EMSculpt & EMSella technology for muscle strength, repair, wellness & longevity Advanced Therapeutic Plasma Exchange for removal of environmental toxins Explore Care Complex Chronic Illness & Cancer Care Integrative diagnostics and targeted therapies for complex chronic illness and cancer support Comprehensive evaluation & treatment for Tickborne infections & Lyme disease, Mold toxicity, MCAS, POTS, Autoimmune disease, Long COVID, and related disorders Adjunctive cancer therapies to support the body alongside conventional care Personalized treatments including Q-Restrain (SOT), mistletoe therapy, PRP, Ten-Pass Ozone, Therapeutic Plasma Exchange & beyond Detoxification, methylation, emotional and nervous-system regulation to restore whole-body balance Explore Care Hormone Therapy & Metabolic Health Hormone optimization and metabolic care to restore balance and overall well-being Comprehensive hormone testing using blood, urine, and saliva Personalized bioidentical hormone replacement therapy (BHRT & TRT) & Peptides Support for metabolic, cognitive, sexual, and emotional health Menopause, perimenopause, postmenopause, and low-testosterone care Personalized weight management and detoxification programs Explore Care Announcements What's New at Holistique EMSCULPT NEO EMSCULPT NEO is an FDA-cleared medical device used to strengthen muscle, improve mobility, and reduce the appearance of localized fat
"It feels like 1 in 10 women having PCOS should be enough to move the needle on what gets covered with insurance, but it is a messy system." For those who can afford to pay out-of-pocket costs, GLP-1s are worth it, Adaya says
Vascular-Signaling Pathways BPC-157 is sometimes discussed in relation to vascular endothelial growth factor, nitric-oxide signaling, endothelial-cell behavior, and capillary-related research models
A 2001 study published in the journal Obesity Research demonstrated that AOD 9604 stimulated lipolysis and inhibited lipogenesis in laboratory settings
